IL323278A - קונסורציומים מיקרוביאליים - Google Patents

קונסורציומים מיקרוביאליים

Info

Publication number
IL323278A
IL323278A IL323278A IL32327825A IL323278A IL 323278 A IL323278 A IL 323278A IL 323278 A IL323278 A IL 323278A IL 32327825 A IL32327825 A IL 32327825A IL 323278 A IL323278 A IL 323278A
Authority
IL
Israel
Prior art keywords
bacteroides
pharmaceutical composition
certain embodiments
consortia
alistipes
Prior art date
Application number
IL323278A
Other languages
English (en)
Inventor
Robert Lee Swen
Joshua J Hamilton
James Berleman
Kyle Jacoby
Ariana M Giglar
Anupreet Parmar
Aditya Bhalla
Pawan Kumar
Original Assignee
Kanvas Biosciences Inc
Robert Lee Swen
Joshua J Hamilton
James Berleman
Kyle Jacoby
Ariana M Giglar
Anupreet Parmar
Aditya Bhalla
Pawan Kumar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanvas Biosciences Inc, Robert Lee Swen, Joshua J Hamilton, James Berleman, Kyle Jacoby, Ariana M Giglar, Anupreet Parmar, Aditya Bhalla, Pawan Kumar filed Critical Kanvas Biosciences Inc
Publication of IL323278A publication Critical patent/IL323278A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL323278A 2023-03-10 2025-09-10 קונסורציומים מיקרוביאליים IL323278A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363451442P 2023-03-10 2023-03-10
US202363469080P 2023-05-26 2023-05-26
PCT/US2024/019341 WO2024191890A2 (en) 2023-03-10 2024-03-11 Microbial consortia

Publications (1)

Publication Number Publication Date
IL323278A true IL323278A (he) 2025-11-01

Family

ID=92755740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL323278A IL323278A (he) 2023-03-10 2025-09-10 קונסורציומים מיקרוביאליים

Country Status (8)

Country Link
EP (1) EP4676500A2 (he)
JP (1) JP2026508937A (he)
KR (1) KR20260020499A (he)
CN (1) CN121175059A (he)
AU (1) AU2024237653A1 (he)
IL (1) IL323278A (he)
MX (1) MX2025010695A (he)
WO (1) WO2024191890A2 (he)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026509899A (ja) * 2023-03-15 2026-03-25 コスト－ビーアールワイ・ピーティーワイ・リミテッド・（トレーディング・アズ・バイオームバンク） 疾患を治療するための微生物叢組成物及び方法
WO2025189253A1 (en) * 2024-03-15 2025-09-18 Cost-Bry Pty Ltd Microbiota compositions and methods for treating disorders
WO2026039405A1 (en) * 2024-08-12 2026-02-19 Kanvas Biosciences, Inc. Microbial consortia for treating or preventing immune-related adverse events
WO2026097016A1 (en) * 2024-11-04 2026-05-07 Rutgers, The State University Of New Jersey Foundation guild transplantation
WO2026101953A1 (en) * 2024-11-05 2026-05-15 Kanvas Biosciences, Inc. Microbial consortia
CN120072056B (zh) * 2025-02-27 2026-07-10 首都医科大学附属北京友谊医院 预测药物对炎症性肠病的疗效的肠道微生物标志物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919906A (zh) * 2016-03-04 2023-04-07 加利福尼亚大学董事会 微生物聚生体及其用途
EP3518946A4 (en) * 2016-09-27 2020-09-09 Board of Regents, The University of Texas System METHODS TO IMPROVE IMMUNE CHECKPOINT BLOCKING TREATMENT BY MODULATING THE MICROBIOME
US20200197449A1 (en) * 2018-12-19 2020-06-25 Crestovo Holdings Llc Compositions and Methods for Treating Alopecia and Related Disorders
AU2021234298A1 (en) * 2020-03-10 2022-09-29 Federation Bio Inc. Microbial consortia for the treatment of disease

Also Published As

Publication number Publication date
JP2026508937A (ja) 2026-03-13
KR20260020499A (ko) 2026-02-11
EP4676500A2 (en) 2026-01-14
AU2024237653A1 (en) 2025-09-25
WO2024191890A8 (en) 2025-10-02
MX2025010695A (es) 2025-12-01
CN121175059A (zh) 2025-12-19
WO2024191890A2 (en) 2024-09-19
WO2024191890A3 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
US20230165913A1 (en) Microbial consortia
JP7409743B2 (ja) 病原性細菌生育の抑制のための組成物および方法
US11666612B2 (en) Network-based microbial compositions and methods
EP4676500A2 (en) Microbial consortia
US20230125976A1 (en) Microbial consortia for the treatment of disease
AU2025226698A1 (en) Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
EP4125441B1 (en) Composition comprising bacterial strains for improving metabolic health
JP2016519664A5 (he)
US20220409674A1 (en) Compositions and methods for suppressing pathogenic organisms
US20250082695A1 (en) Use of glycerol for increasing butyrate production by bacteria in a consortium
CN117866831A (zh) 一种鼠李糖乳酪杆菌及其应用
CN114728028A (zh) 包括具有增强的持久性的新微生物的组合物、新微生物和益生元的协同组合
IL324233A (he) הרכבים המכילים קונסורציום של חיידקים
US20260007704A1 (en) Microbial consortia
WO2026039405A1 (en) Microbial consortia for treating or preventing immune-related adverse events